Evidence map›Paper›PMID 34628512›Full record

ArticleArchives of toxicology2021

Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling.

Dominik Loser, Karin Grillberger, Maria G Hinojosa, Jonathan Blum, Yves Haufe, Timm Danker, Ylva Johansson, Clemens Möller, Annette Nicke, Susanne H Bennekou and 7 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 5 countries.

Dominik LoserNMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.ORCID http://orcid.org/0000-0002-2513-238X
Karin GrillbergerDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Maria G HinojosaDepartment of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.
Jonathan BlumIn Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457, Konstanz, Germany.
Yves HaufeWalther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, 80336, Munich, Germany.
Timm DankerNMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.
Ylva JohanssonDepartment of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.
Clemens MöllerLife Sciences Faculty, Albstadt-Sigmaringen University, 72488, Sigmaringen, Germany.
Annette NickeWalther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, 80336, Munich, Germany.
Susanne H BennekouTechnical University of Denmark, Kongens Lyngby, Denmark.
Iain GardnerCERTARA UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.
Caroline BauchCyprotex Discovery Ltd, No. 24 Mereside, Alderley Park, Cheshire, SK10 4TG, UK.
Paul WalkerCyprotex Discovery Ltd, No. 24 Mereside, Alderley Park, Cheshire, SK10 4TG, UK.
Anna ForsbyDepartment of Biochemistry and Biophysics, Stockholm University, 106 91, Stockholm, Sweden.
Gerhard F EckerDepartment of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Udo Kraushaar *NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.
Marcel Leist *In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457, Konstanz, Germany. marcel.leist@uni-konstanz.de.
Stockholm University · SEUniversity of Konstanz · DEC4X Discovery (United Kingdom) · GBLudwig-Maximilians-Universität München · DENatural and Medical Sciences Institute · DEUniversity of Vienna · ATAlbstadt-Sigmaringen University · DESimcyp (United Kingdom) · GBTechnical University of Denmark · DK

Funding

Deutsche Forschungsgemeinschaft Research Training Group GRK 2338, P01Horizon 2020 681002Horizon 2020 825759Horizon 2020 964518Horizon 2020 964537Miljøstyrelsen MST-667-00205Senatsverwaltung für Bildung, Jugend und Wissenschaft, Berlin LTB-P769Vetenskapsrådet VR-2018-03269
6 · The paper itself

Abstract

Several neonicotinoids have recently been shown to activate the nicotinic acetylcholine receptor (nAChR) on human neurons. Moreover, imidacloprid (IMI) and other members of this pesticide family form a set of diverse metabolites within crops. Among these, desnitro-imidacloprid (DN-IMI) is of special toxicological interest, as there is evidence (i) for human dietary exposure to this metabolite, (ii) and that DN-IMI is a strong trigger of mammalian nicotinic responses. We set out here to quantify responses of human nAChRs to DN-IMI and an alternative metabolite, IMI-olefin. To evaluate toxicological hazards, these data were then compared to those of IMI and nicotine. Ca

Indexed as

AlkenesAnimalsCell LineCell Line, TumorHumansImidazolinesMolecular Docking SimulationNeonicotinoidsNeuroblastomaNeuronsNicotinic AgonistsNitro CompoundsOocytesPesticidesPyridinesReceptors, NicotinicAlkenesdesnitroimidaclopridimidaclopridImidazolinesNeonicotinoidsNicotinic AgonistsNitro CompoundsPesticidesPyridinesReceptors, NicotinicDevelopmental neurotoxicityLive-cell calcium imagingMolecular dockingNicotineOocyte recordingPesticide metabolism

Identifiers

PMID34628512
PMCPMC8536575
OpenAlexW3206856143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.